According to health professionals, Mycoplasma genitalium is developing resistance to antibiotics at an alarming rate. Much like chlamydia, many people do not know when they have it, but it can increase the risk of pelvic inflammatory disease, urethritis and spontaneous abortion in those infected. Health groups have raised the alarm at the bacteria’s ability to develop a strong resistance to antibiotics, particularly the drug azithromycin, which until recently had been a reliable defence.
Fortunately ResistancePlusTM MG not only helps detect the Mycoplasma genitalium infection, but can also support treatment decisions by providing detection of specific azithromycin resistance markers.
Read the full article here